Onward Medical is a neurotechnology company developing neuromodulation therapies aimed at restoring motor and autonomic function in people with spinal cord injury. The company focuses on targeted electrical stimulation of neural circuits below and above the site of injury to re-enable functional movement and physiological control.

Its platform includes implantable spinal cord stimulation systems as well as non-invasive stimulation approaches, combined with structured rehabilitation protocols. These systems are designed to modulate spinal and supraspinal networks to promote functional recovery through activity-dependent plasticity.

Onward Medical’s technology is being advanced through clinical trials and translational research, with applications including restoration of walking, upper-limb function, and blood pressure regulation. The company positions itself at the intersection of neuromodulation and neurorehabilitation, focusing on clinically meaningful functional outcomes rather than symptomatic management alone.